Covid-19 Impact on Grayline – Update

As the number of COVID-19 cases continue to rise in the U.S., our pharmaceutical representatives have decided to stall their studies. All this means, is that we cannot recruit new patients, but we are open and here to talk about our studies and take your information for when the studies resume! If you or someone you know is mentally struggling with this pandemic and quarantine, please feel free to refer them to us. We will always be here to help our community and can assist those struggling by directing them to more immediate help! 940-322-1131